The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications

导出原文传递

翻译打印收藏纠错

作者： Ostroumova, O. D. ^[1] ; Kochetkov, A., I ^[2] ; Pereverzev, A. P. ; Kravchenko, E., V ; Kazjulin, A. N. ; Andreev, D. N. ; Pavleeva, E. E.

作者单位： Pirogov Russian Natl Res Med Univ, Russian Clin & Res Ctr Gerontol, Moscow, Russia ^[1] Yevdokimov Moscow State Univ Med & Dent, Moscow, Russia ^[2]

关键词 proton pump inhibitor clopidogrel dual antiplatelet therapy coronary artery disease percutaneous coronary intervention adverse cardiovascular outcomes drug interaction

发布时间 2019-11-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Терапевтичесκий архив

2019年91卷8期

118-126页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications

Терапевтичесκий архив

相似文献

Терапевтичесκий архив

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications

Терапевтичесκий архив

相似文献

Терапевтичесκий архив

相关期刊

检索历史清除